Salt, chloride, bleach, and innate host defense

Journal of Leukocyte Biology

Volumn 98, Issue 2, 2015, Pages 163-172

  Wang, Guoshun ^a   Nauseef, William M ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Hypochlorous acid; Myeloperoxidase; Neutrophil oxidants; Phagocytes

Indexed keywords

BLEACHING AGENT; CATION; CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; SODIUM CHLORIDE; VOLTAGE GATED CHLORIDE CHANNEL; CFTR PROTEIN, HUMAN; HYPOCHLOROUS ACID;

ANTIMICROBIAL ACTIVITY; CHLORIDE CHANNELOPATHY; HOMEOSTASIS; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; NEUTROPHIL; PHAGOCYTE; PHAGOSOME; PRIORITY JOURNAL; REVIEW; CANDIDA ALBICANS; CANDIDIASIS; CYSTIC FIBROSIS; IMMUNOLOGY; LEUKOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

CANDIDA ALBICANS; CANDIDIASIS; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; HYPOCHLOROUS ACID; IMMUNITY, INNATE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHAGOCYTES; PHAGOSOMES; SODIUM CHLORIDE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84938338059     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.4RU0315-109R     Document Type: Review

References (168)

1. Frisoli, T. M., Schmieder, R. E., Grodzicki, T., Messerli, F. H. (2012) Salt and hypertension: is salt dietary reduction worth the effort? Am. J. Med. 125, 433–439
2. Cirillo, M., Capasso, G., Di Leo, V. A., De Santo, N. G. (1994) A history of salt. Am. J. Nephrol. 14, 426–431
3. Kotchen, T. A., Cowley, Jr., A. W., Frohlich, E. D. (2013) Salt in health and disease—a delicate balance. N. Engl. J. Med. 368, 1229–1237
4. Weller, O., Dumitroaia, G. (2005) The earliest salt production in the world: an early Neolithic exploitation in Poiana Slatinei-Lunca, Romania. Antiquity 79, 1–4
5. Kurlansky, M. (2002) Salt: A World History. Walker and Co., New York.
6. Denton, D. (1982) The Hunger for Salt. An Anthropological, Physiological and Medical Analysis. Springer-Verlag, Berlin, Heidelberg, New York.
7. Ritz, E. (1996) The history of salt—aspects of interest to the nephrologist. Nephrol. Dial. Transplant. 11, 969–975 (http://www.academia.edu/936358).
8. Greig, E. D. (1946) The treatment of cholera by intravenous saline injections; with particular reference to the contributions of Dr. Thomas Aitchison Latta of Leith. Edinburgh Med. J. 53, 256–263
9. Baskett, T. F. (2002) William O’Shaughnessy, Thomas Latta and the origins of intravenous saline. Resuscitation 55, 231–234
10. Cunliffe, P. J., Fawcett, T. N. (2002) Wound cleansing: the evidence for the techniques and solutions used. Prof. Nurse 18, 95–99
11. Marthaler, T. M. (2013) Salt fluoridation and oral health. Acta Med. Acad. 42, 140–155
12. Adler-Cohen, C., Czarnowicki, T., Dreiher, J., Ruzicka, T., Ingber, A., Harari, M. (2012) Climatotherapy at the Dead Sea: an effective treatment modality for atopic dermatitis with significant positive impact on quality of life. Dermatitis 23, 75–80
13. Chervinskaya, A. V., Zilber, N. A. (1995) Halotherapy for treatment of respiratory diseases. J. Aerosol Med. 8, 221–232
14. Da Dalt, L., Bressan, S., Martinolli, F., Perilongo, G., Baraldi, E. (2013) Treatment of bronchiolitis: state of the art. Early Hum. Dev. 89 (Suppl 1), S31–S36
15. Nagakumar, P., Doull, I. (2012) Current therapy for bronchiolitis. Arch. Dis. Child. 97, 827–830
16. Kellett, F., Robert, N. M. (2011) Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Respir. Med. 105, 1831–1835
17. Reeves, E. P., McElvaney, N. G. (2012) The facilitating effect of hypertonic saline on resolution of airway inflammation in cystic fibrosis. Am. J. Respir. Crit. Care Med. 185, 226–227
18. Reeves, E. P., Molloy, K., Pohl, K., McElvaney, N. G. (2012) Hypertonic saline in treatment of pulmonary disease in cystic fibrosis. ScientificWorldJournal 2012, 465230
19. Nightingale, J., Woodward, J. M.; Small Bowel and Nutrition Committee of the British Society of Gastroenterology. (2006) Guidelines for management of patients with a short bowel. Gut 55 (Suppl 4), iv1–iv12
20. Human Microbiome Project Consortium. (2012) Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214
21. Underhill, D. M., Ozinsky, A. (2002) Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20, 825–852
22. Flannagan, R. S., Jaumouillé, V., Grinstein, S. (2012) The cell biology of phagocytosis. Annu. Rev. Pathol. 7, 61–98
23. Metchnikoff, E. (1905) Immunity in Infective Diseases. Cambridge University Press, London, UK.
24. Cavaillon, J. M. (2011) The historical milestones in the understanding of leukocyte biology initiated by Elie Metchnikoff. J. Leukoc. Biol. 90, 413–424
25. Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., Zychlinsky, A. (2012) Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30, 459–489
26. Nathan, C. (2006) Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173–182
27. Nauseef, W. M. (2007) How human neutrophils kill and degrade microbes: an integrated view. Immunol. Rev. 219, 88–102
28. Nauseef, W. M. (2008) Biological roles for the NOX family NADPH oxidases. J. Biol. Chem. 283, 16961–16965
29. Babior, B. M. (2004) NADPH oxidase. Curr. Opin. Immunol. 16, 42–47
30. Yagisawa, M., Yuo, A., Yonemaru, M., Imajoh-Ohmi, S., Kanegasaki, S., Yazaki, Y., Takaku, F. (1996) Superoxide release and NADPH oxidase components in mature human phagocytes: correlation between functional capacity and amount of functional proteins. Biochem. Biophys. Res. Commun. 228, 510–516
31. Decoursey, T. E. (2003) Voltage-gated proton channels and other proton transfer pathways. Physiol. Rev. 83, 475–579
32. DeCoursey, T. E., Morgan, D., Cherny, V. V. (2003) The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels. Nature 422, 531–534
33. Demaurex, N., El Chemaly, A. (2010) Physiological roles of voltagegated proton channels in leukocytes. J. Physiol. 588, 4659–4665
34. Ramsey, I. S., Moran, M. M., Chong, J. A., Clapham, D. E. (2006) A voltage-gated proton-selective channel lacking the pore domain. Nature 440, 1213–1216
35. Sasaki, M., Takagi, M., Okamura, Y. (2006) A voltage sensor-domain protein is a voltage-gated proton channel. Science 312, 589–592
36. Chvapil, M., Stankova, L., Zukoski IV, C., Zukoski III, C. (1977) Inhibition of some functions of polymorphonuclear leukocytes by in vitro zinc. J. Lab. Clin. Med. 89, 135–146
37. Ramsey, I. S., Ruchti, E., Kaczmarek, J. S., Clapham, D. E. (2009) Hv1 proton channels are required for high-level NADPH oxidase-dependent superoxide production during the phagocyte respiratory burst. Proc. Natl. Acad. Sci. USA 106, 7642–7647
38. El Chemaly, A., Okochi, Y., Sasaki, M., Arnaudeau, S., Okamura, Y., Demaurex, N. (2010) VSOP/Hv1 proton channels sustain calcium entry, neutrophil migration, and superoxide production by limiting cell depolarization and acidification. J. Exp. Med. 207, 129–139
39. Klebanoff, S. J. (1968) Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J. Bacteriol. 95, 2131–2138
40. Klebanoff, S. J., Kettle, A. J., Rosen, H., Winterbourn, C. C., Nauseef, W. M. (2013) Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J. Leukoc. Biol. 93, 185–198
41. Winterbourn, C. C., Hampton, M. B., Livesey, J. H., Kettle, A. J. (2006) Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J. Biol. Chem. 281, 39860–39869
42. Foote, C. S., Goyne, T. E., Lehrer, R. I. (1983) Assessment of chlorination by human neutrophils. Nature 301, 715–716
43. Weiss, S. J., Klein, R., Slivka, A., Wei, M. (1982) Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J. Clin. Invest. 70, 598–607
44. Thomas, E. L., Grisham, M. B., Jefferson, M. M. (1983) Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J. Clin. Invest. 72, 441–454
45. Chapman, A. L., Hampton, M. B., Senthilmohan, R., Winterbourn, C. C., Kettle, A. J. (2002) Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J. Biol. Chem. 277, 9757–9762
46. Rutala, W. A., Weber, D. J. (1997) Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin. Microbiol. Rev. 10, 597–610
47. Winterbourn, C. C., Kettle, A. J. (2013) Redox reactions and microbial killing in the neutrophil phagosome. Antioxid. Redox Signal. 18, 642–660
48. Hurst, J. K. (2012) What really happens in the neutrophil phagosome? Free Radic. Biol. Med. 53, 508–520
49. Davies, M. J. (2011) Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J. Clin. Biochem. Nutr. 48, 8–19
50. Pattison, D. I., Hawkins, C. L., Davies, M. J. (2009) What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Chem. Res. Toxicol. 22, 807–817
51. Pattison, D. I., Davies, M. J. (2001) Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem. Res. Toxicol. 14, 1453–1464
52. Deborde, M., von Gunten, U. (2008) Reactions of chlorine with inorganic and organic compounds during water treatment-kinetics and mechanisms: a critical review. Water Res. 42, 13–51
53. Peskin, A. V., Turner, R., Maghzal, G. J., Winterbourn, C. C., Kettle, A. J. (2009) Oxidation of methionine to dehydromethionine by reactive halogen species generated by neutrophils. Biochemistry 48, 10175–10182
54. Ronsein, G. E., Winterbourn, C. C., Di Mascio, P., Kettle, A. J. (2014) Cross-linking methionine and amine residues with reactive halogen species. Free Radic. Biol. Med. 70, 278–287
55. Rosen, H., Klebanoff, S. J., Wang, Y., Brot, N., Heinecke, J. W., Fu, X. (2009) Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils. Proc. Natl. Acad. Sci. USA 106, 18686–18691
56. Hurst, J. K., Albrich, J. M., Green, T. R., Rosen, H., Klebanoff, S. (1984) Myeloperoxidase-dependent fluorescein chlorination by stimulated neutrophils. J. Biol. Chem. 259, 4812–4821
57. Nauseef, W. M. (2014) Myeloperoxidase in human neutrophil host defence. Cell. Microbiol. 16, 1146–1155
58. Imlay, J. A. (2003) Pathways of oxidative damage. Annu. Rev. Microbiol. 57, 395–418
59. Albrich, J. M., Hurst, J. K. (1982) Oxidative inactivation of Escherichia coli by hypochlorous acid. Rates and differentiation of respiratory from other reaction sites. FEBS Lett. 144, 157–161
60. Lymar, S. V., Hurst, J. K. (1995) Role of compartmentation in promoting toxicity of leukocyte-generated strong oxidants. Chem. Res. Toxicol. 8, 833–840
61. Hirche, T. O., Gaut, J. P., Heinecke, J. W., Belaaouaj, A. (2005) Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense. J. Immunol. 174, 1557–1565
62. Simchowitz, L., De Weer, P. (1986) Chloride movements in human neutrophils. Diffusion, exchange, and active transport. J. Gen. Physiol. 88, 167–194
63. Ince, C., Thio, B., van Duijn, B., van Dissel, J. T., Ypey, D. L., Leijh, P. C. (1987) Intracellular K+, Na+ and Cl2 concentrations and membrane potential in human monocytes. Biochim. Biophys. Acta 905, 195–204
64. Baron, D. N., Ahmed, S. A. (1969) Intracellular concentrations of water and of the principal electrolytes determined by analysis of isolated human leucocytes. Clin. Sci. 37, 205–219
65. Busetto, S., Trevisan, E., Decleva, E., Dri, P., Menegazzi, R. (2007) Chloride movements in human neutrophils during phagocytosis: characterization and relationship to granule release. J. Immunol. 179, 4110–4124
66. Green, J. N., Kettle, A. J., Winterbourn, C. C. (2014) Protein chlorination in neutrophil phagosomes and correlation with bacterial killing. Free Radic. Biol. Med. 77, 49–56
67. Painter, R. G., Wang, G. (2006) Direct measurement of free chloride concentrations in the phagolysosomes of human neutrophils. Anal. Chem. 78, 3133–3137
68. Painter, R. G., Marrero, L., Lombard, G. A., Valentine, V. G., Nauseef, W. M., Wang, G. (2010) CFTR-mediated halide transport in phagosomes of human neutrophils. J. Leukoc. Biol. 87, 933–942
69. Planells-Cases, R., Jentsch, T. J. (2009) Chloride channelopathies. Biochim. Biophys. Acta 1792, 173–189
70. Duran, C., Thompson, C. H., Xiao, Q., Hartzell, H. C. (2010) Chloride channels: often enigmatic, rarely predictable. Annu. Rev. Physiol. 72, 95–121
71. Verkman, A. S., Galietta, L. J. (2009) Chloride channels as drug targets. Nat. Rev. Drug Discov. 8, 153–171
72. Sheppard, D. N., Welsh, M. J. (1999) Structure and function of the CFTR chloride channel. Physiol. Rev. 79 ((1): Suppl) S23–S45
73. Riordan, J. R. (2005) Assembly of functional CFTR chloride channels. Annu. Rev. Physiol. 67, 701–718
74. Zifarelli, G., Pusch, M. (2007) CLC chloride channels and transporters: a biophysical and physiological perspective. Rev. Physiol. Biochem. Pharmacol. 158, 23–76
75. Caputo, A., Caci, E., Ferrera, L., Pedemonte, N., Barsanti, C., Sondo, E., Pfeffer, U., Ravazzolo, R., Zegarra-Moran, O., Galietta, L. J. (2008) TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 322, 590–594
76. Hartzell, C., Putzier, I., Arreola, J. (2005) Calcium-activated chloride channels. Annu. Rev. Physiol. 67, 719–758
77. Schroeder, B. C., Cheng, T., Jan, Y. N., Jan, L. Y. (2008) Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 134, 1019–1029
78. Yang, Y. D., Cho, H., Koo, J. Y., Tak, M. H., Cho, Y., Shim, W. S., Park, S. P., Lee, J., Lee, B., Kim, B. M., Raouf, R., Shin, Y. K., Oh, U. (2008) TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 455, 1210–1215
79. Pifferi, S., Dibattista, M., Menini, A. (2009) TMEM16B induces chloride currents activated by calcium in mammalian cells. Pflugers Arch. 458, 1023–1038
80. Stöhr, H., Heisig, J. B., Benz, P. M., Schöberl, S., Milenkovic, V. M., Strauss, O., Aartsen, W. M., Wijnholds, J., Weber, B. H., Schulz, H. L. (2009) TMEM16B, a novel protein with calcium-dependent chloride channel activity, associates with a presynaptic protein complex in photoreceptor terminals. J. Neurosci. 29, 6809–6818
81. Sigel, E., Steinmann, M. E. (2012) Structure, function, and modulation of GABA(A) receptors. J. Biol. Chem. 287, 40224–40231
82. Avila, A., Nguyen, L., Rigo, J. M. (2013) Glycine receptors and brain development. Front. Cell. Neurosci. 7, 184
83. Hoffmann, E. K., Lambert, I. H., Pedersen, S. F. (2009) Physiology of cell volume regulation in vertebrates. Physiol. Rev. 89, 193–277
84. Yoshimura, K., Nakamura, H., Trapnell, B. C., Chu, C. S., Dalemans, W., Pavirani, A., Lecocq, J. P., Crystal, R. G. (1991) Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of nonepithelial origin. Nucleic Acids Res. 19, 5417–5423
85. Painter, R. G., Valentine, V. G., Lanson, Jr., N. A., Leidal, K., Zhang, Q., Lombard, G., Thompson, C., Viswanathan, A., Nauseef, W. M., Wang, G., Wang, G. (2006) CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 45, 10260–10269
86. Di, A., Brown, M. E., Deriy, L. V., Li, C., Szeto, F. L., Chen, Y., Huang, P., Tong, J., Naren, A. P., Bindokas, V., Palfrey, H. C., Nelson, D. J. (2006) CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat. Cell Biol. 8, 933–94
87. Moreland, J. G., Davis, A. P., Bailey, G., Nauseef, W. M., Lamb, F. S. (2006) Anion channels, including ClC-3, are required for normal neutrophil oxidative function, phagocytosis, and transendothelial migration. J. Biol. Chem. 281, 12277–12288
88. Alex, P., Ye, M., Zachos, N. C., Sipes, J., Nguyen, T., Suhodrev, M., Gonzales, L., Arora, Z., Zhang, T., Centola, M., Guggino, S. E., Li, X. (2010) Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis. J. Immunol. 184, 3988–3996
89. Riordan, J. R., et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066–1073
90. Lukacs, G. L., Verkman, A. S. (2012) CFTR: folding, misfolding and correcting the DF508 conformational defect. Trends Mol. Med. 18, 81–91
91. Zhou, Y., Song, K., Painter, R. G., Aiken, M., Reiser, J., Stanton, B. A., Nauseef, W. M., Wang, G. (2013) Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutrophils. J. Innate Immun. 5, 219–230
92. Su, X., Looney, M. R., Su, H. E., Lee, J. W., Song, Y., Matthay, M. A. (2011) Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice. Inflamm. Res. 60, 619–632
93. Yoshimura, K., Rosenfeld, M. A., Nakamura, H., Scherer, E. M., Pavirani, A., Lecocq, J. P., Crystal, R. G. (1992) Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res. 20, 3233–3240
94. Painter, R. G., Bonvillain, R. W., Valentine, V. G., Lombard, G. A., LaPlace, S. G., Nauseef, W. M., Wang, G. (2008) The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. J. Leukoc. Biol. 83, 1345–1353
95. Phennicie, R. T., Sullivan, M. J., Singer, J. T., Yoder, J. A., Kim, C. H. (2010) Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator. Infect. Immun. 78, 4542–4550
96. Ng, H. P., Zhou, Y., Song, K., Hodges, C. A., Drumm, M. L., Wang, G. (2014) Neutrophil-mediated phagocytic host defense defect in myeloid Cftr-inactivated mice. PLoS ONE 9, e106813
97. Picollo, A., Pusch, M. (2005) Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 436, 420–423
98. Scheel, O., Zdebik, A. A., Lourdel, S., Jentsch, T. J. (2005) Voltagedependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature 436, 424–427
99. Stauber, T., Weinert, S., Jentsch, T. J. (2012) Cell biology and physiology of CLC chloride channels and transporters. Compr. Physiol. 2, 1701–1744
100. Matsuda, J. J., Filali, M. S., Collins, M. M., Volk, K. A., Lamb, F. S. (2010) The ClC-3 Cl2/H+ antiporter becomes uncoupled at low extracellular pH. J. Biol. Chem. 285, 2569–2579
101. Huynh, K. K., Grinstein, S. (2007) Regulation of vacuolar pH and its modulation by some microbial species. Microbiol. Mol. Biol. Rev. 71, 452–462
102. Jankowski, A., Scott, C. C., Grinstein, S. (2002) Determinants of the phagosomal pH in neutrophils. J. Biol. Chem. 277, 6059–6066
103. Miller, Jr., F. J., Filali, M., Huss, G. J., Stanic, B., Chamseddine, A., Barna, T. J., Lamb, F. S. (2007) Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ. Res. 101, 663–671
104. Murphy, R., DeCoursey, T. E. (2006) Charge compensation during the phagocyte respiratory burst. Biochim. Biophys. Acta 1757, 996–1011
105. DeCoursey, T. E. (2010) Voltage-gated proton channels find their dream job managing the respiratory burst in phagocytes. Physiology (Bethesda) 25, 27–40
106. Morgan, D., Capasso, M., Musset, B., Cherny, V. V., Ríos, E., Dyer, M. J., DeCoursey, T. E. (2009) Voltage-gated proton channels maintain pH in human neutrophils during phagocytosis. Proc. Natl. Acad. Sci. USA 106, 18022–18027
107. El Chemaly, A., Nunes, P., Jimaja, W., Castelbou, C., Demaurex, N. (2014) Hv1 proton channels differentially regulate the pH of neutrophil and macrophage phagosomes by sustaining the production of phagosomal ROS that inhibit the delivery of vacuolar ATPases. J. Leukoc. Biol. 95, 827–839
108. Forgac, M. (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 8, 917–929
109. Nishi, T., Forgac, M. (2002) The vacuolar (H+)-ATPases—nature’s most versatile proton pumps. Nat. Rev. Mol. Cell Biol. 3, 94–103
110. Marshansky, V., Rubinstein, J. L., Grüber, G. (2014) Eukaryotic VATPase: novel structural findings and functional insights. Biochim. Biophys. Acta 1837, 857–879
111. Breton, S., Brown, D. (2013) Regulation of luminal acidification by the V-ATPase. Physiology (Bethesda) 28, 318–329
112. Steinberg, B. E., Touret, N., Vargas-Caballero, M., Grinstein, S. (2007) In situ measurement of the electrical potential across the phagosomal membrane using FRET and its contribution to the proton-motive force. Proc. Natl. Acad. Sci. USA 104, 9523–9528
113. Sun, Y. T., Shieh, C. C., Delpire, E., Shen, M. R. (2012) K⁺-Cl⁻ cotransport mediates the bactericidal activity of neutrophils by regulating NADPH oxidase activation. J. Physiol. 590, 3231–3243
114. Adragna, N. C., Di Fulvio, M., Lauf, P. K. (2004) Regulation of K-Cl cotransport: from function to genes. J. Membr. Biol. 201, 109–137
115. Gamba, G. (2005) Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. Physiol. Rev. 85, 423–493
116. Grinstein, S., Furuya, W., Cragoe, Jr., E. J. (1986) Volume changes in activated human neutrophils: the role of Na+/H+ exchange. J. Cell. Physiol. 128, 33–40
117. Pedemonte, N., Galietta, L. J. (2014) Structure and function of TMEM16 proteins (anoctamins). Physiol. Rev. 94, 419–459
118. Huang, F., Rock, J. R., Harfe, B. D., Cheng, T., Huang, X., Jan, Y. N., Jan, L. Y. (2009) Studies on expression and function of the TMEM16A calcium-activated chloride channel. Proc. Natl. Acad. Sci. USA 106, 21413–21418
119. Large, W. A., Wang, Q. (1996) Characteristics and physiological role of the Ca(2+)-activated Cl2 conductance in smooth muscle. Am. J. Physiol. 271, C435–C454
120. Murphy, P. M. (1997) Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin. Hematol. 34, 311–318
121. Murphy, P. M. (1994) The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12, 593–633
122. Collins, F. S. (1992) Cystic fibrosis: molecular biology and therapeutic implications. Science 256, 774–779
123. Welsh, M. J., Ramsey, B. W., Accurso, F., Cutting, G. (2001) Cystic fibrosis. In Metabolic and Molecular Basis of Interited Disease. (C. R. Scriver, ed.), McGraw-Hill, New York, 5121–5188
124. Stoltz, D. A., Meyerholz, D. K., Pezzulo, A. A., Ramachandran, S., Rogan, M. P., Davis, G. J., Hanfland, R. A., Wohlford-Lenane, C., Dohrn, C. L., Bartlett, J. A., Nelson IV, G. A., Chang, E.H., Taft, P. J., Ludwig, P. S., Estin, M., Hornick, E. E., Launspach, J. L., Samuel, M., Rokhlina, T., Karp, P. H., Ostedgaard, L. S., Uc, A., Starner, T. D., Horswill, A. R., Brogden, K. A., Prather, R. S., Richter, S. S., Shilyansky, J., McCray, Jr., P. B., Zabner, J., Welsh, M. J. (2010) Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 2, 29ra31
125. Hampton, T. H., Ballok, A. E., Bomberger, J. M., Rutkowski, M. R., Barnaby, R., Coutermarsh, B., Conejo-Garcia, J. R., O’Toole, G. A., Stanton, B. A. (2012) Does the F508-CFTR mutation induce a proinflammatory response in human airway epithelial cells? Am. J. Physiol. Lung Cell. Mol. Physiol. 303, L509–L518
126. Davis, P. B., Drumm, M., Konstan, M. W. (1996) Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154, 1229–1256
127. Segal, B. H., Grimm, M. J., Khan, A. N., Han, W., Blackwell, T. S. (2012) Regulation of innate immunity by NADPH oxidase. Free Radic. Biol. Med. 53, 72–80
128. Porter, L. A., Goldberg, J. B. (2011) Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis. Front. Cell. Infect. Microbiol. 1, 9
129. Berendes, H., Bridges, R. A., Good, R. A. (1957) A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn. Med. 40, 309–312
130. Holmes, B., Page, A. R., Good, R. A. (1967) Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J. Clin. Invest. 46, 1422–1432
131. Matute, J. D., Arias, A. A., Wright, N. A., Wrobel, I., Waterhouse, C. C., Li, X. J., Marchal, C. C., Stull, N. D., Lewis, D. B., Steele, M., Kellner, J. D., Yu, W., Meroueh, S. O., Nauseef, W. M., Dinauer, M. C. (2009) A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 114, 3309–3315
132. Cohen, T. S., Prince, A. (2012) Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat. Med. 18, 509–519
133. Knowles, M. R., Boucher, R. C. (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109, 571–577
134. Boucher, R. C. (2003) Regulation of airway surface liquid volume by human airway epithelia. Pflugers Arch. 445, 495–498
135. Pezzulo, A. A., Tang, X. X., Hoegger, M. J., Alaiwa, M. H., Ramachandran, S., Moninger, T. O., Karp, P. H., Wohlford-Lenane, C. L., Haagsman, H. P., van Eijk, M., Bánfi, B., Horswill, A. R., Stoltz, D. A., McCray, Jr., P. B., Welsh, M. J., Zabner, J. (2012) Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487, 109–113
136. Schutte, B. C., McCray, Jr., P. B. (2002) [beta]-Defensins in lung host defense. Annu. Rev. Physiol. 64, 709–748
137. Bonfield, T. L., Hodges, C. A., Cotton, C. U., Drumm, M. L. (2012) Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection. J. Leukoc. Biol. 92, 1111–1122
138. Berend, K., van Hulsteijn, L. H., Gans, R. O. (2012) Chloride: the queen of electrolytes? Eur. J. Intern. Med. 23, 203–211
139. Dickerson, L. W., Bonthius, D. J., Schutte, B. C., Yang, B., Barna, T. J., Bailey, M. C., Nehrke, K., Williamson, R. A., Lamb, F. S. (2002) Altered GABAergic function accompanies hippocampal degeneration in mice lacking ClC-3 voltage-gated chloride channels. Brain Res. 958, 227–250
140. Stobrawa, S. M., Breiderhoff, T., Takamori, S., Engel, D., Schweizer, M., Zdebik, A. A., Bösl, M. R., Ruether, K., Jahn, H., Draguhn, A., Jahn, R., Jentsch, T. J. (2001) Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron 29, 185–196
141. Yoshikawa, M., Uchida, S., Ezaki, J., Rai, T., Hayama, A., Kobayashi, K., Kida, Y., Noda, M., Koike, M., Uchiyama, Y., Marumo, F., Kominami, E., Sasaki, S. (2002) CLC-3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis. Genes Cells 7, 597–605
142. Volk, A. P., Heise, C. K., Hougen, J. L., Artman, C. M., Volk, K. A., Wessels, D., Soll, D. R., Nauseef, W. M., Lamb, F. S., Moreland, J. G. (2008) ClC-3 and IClswell are required for normal neutrophil chemotaxis and shape change. J. Biol. Chem. 283, 34315–34326
143. Piwon, N., Günther, W., Schwake, M., Bösl, M. R., Jentsch, T. J. (2000) ClC-5 Cl2 -channel disruption impairs endocytosis in a mouse model for Dent’s disease. Nature 408, 369–373
144. De Stefano, S., Pusch, M., Zifarelli, G. (2013) A single point mutation reveals gating of the human ClC-5 Cl2/H+ antiporter. J. Physiol. 591, 5879–5893
145. Novarino, G., Weinert, S., Rickheit, G., Jentsch, T. J. (2010) Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science 328, 1398–1401
146. Raggi, C., Fujiwara, K., Leal, T., Jouret, F., Devuyst, O., Terryn, S. (2011) Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent’s disease. Pflugers Arch. 462, 851–860
147. Kasper, D., Planells-Cases, R., Fuhrmann, J. C., Scheel, O., Zeitz, O., Ruether, K., Schmitt, A., Pöet, M., Steinfeld, R., Schweizer, M., Kornak, U., Jentsch, T. J. (2005) Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 24, 1079–1091
148. Kornak, U., Kasper, D., Bösl, M. R., Kaiser, E., Schweizer, M., Schulz, A., Friedrich, W., Delling, G., Jentsch, T. J. (2001) Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205–215
149. Pöet, M., Kornak, U., Schweizer, M., Zdebik, A. A., Scheel, O., Hoelter, S., Wurst, W., Schmitt, A., Fuhrmann, J. C., Planells-Cases, R., Mole, S. E., Hübner, C. A., Jentsch, T. J. (2006) Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6. Proc. Natl. Acad. Sci. USA 103, 13854–13859
150. Graves, A. R., Curran, P. K., Smith, C. L., Mindell, J. A. (2008) The Cl2/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 453, 788–792
151. Neagoe, I., Stauber, T., Fidzinski, P., Bergsdorf, E. Y., Jentsch, T. J. (2010) The late endosomal ClC-6 mediates proton/chloride countertransport in heterologous plasma membrane expression. J. Biol. Chem. 285, 21689–21697
152. Pressey, S. N., O’Donnell, K. J., Stauber, T., Fuhrmann, J. C., Tyynelä, J., Jentsch, T. J., Cooper, J. D. (2010) Distinct neuropathologic phenotypes after disrupting the chloride transport proteins ClC-6 or ClC-7/Ostm1. J. Neuropathol. Exp. Neurol. 69, 1228–1246
153. Weinert, S., Jabs, S., Supanchart, C., Schweizer, M., Gimber, N., Richter, M., Rademann, J., Stauber, T., Kornak, U., Jentsch, T. J. (2010) Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl2 accumulation. Science 328, 1401–1403
154. Wartosch, L., Fuhrmann, J. C., Schweizer, M., Stauber, T., Jentsch, T. J. (2009) Lysosomal degradation of endocytosed proteins depends on the chloride transport protein ClC-7. FASEB J. 23, 4056–4068
155. Rock, J. R., O’Neal, W. K., Gabriel, S. E., Randell, S. H., Harfe, B. D., Boucher, R. C., Grubb, B. R. (2009) Transmembrane protein 16A (TMEM16A) is a Ca2+-regulated Cl2 secretory channel in mouse airways. J. Biol. Chem. 284, 14875–14880
156. Billig, G. M., Pál, B., Fidzinski, P., Jentsch, T. J. (2011) Ca2+-activated Cl2 currents are dispensable for olfaction. Nat. Neurosci. 14, 763–769
157. Hwang, S. J., Blair, P. J., Britton, F. C., O’Driscoll, K. E., Hennig, G., Bayguinov, Y. R., Rock, J. R., Harfe, B. D., Sanders, K. M., Ward, S. M. (2009) Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal is fundamental for slow wave activity in gastrointestinal muscles. J. Physiol. 587, 4887–4904
158. Frings, S., Reuter, D., Kleene, S. J. (2000) Neuronal Ca2+ -activated Cl2 channels—homing in on an elusive channel species. Prog. Neurobiol. 60, 247–289
159. Duan, D. (2009) Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart. J. Physiol. 587, 2163–2177
160. Cho, H., Yang, Y. D., Lee, J., Lee, B., Kim, T., Jang, Y., Back, S. K., Na, H. S., Harfe, B. D., Wang, F., Raouf, R., Wood, J. N., Oh, U. (2012) The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons. Nat. Neurosci. 15, 1015–1021
161. Duran, C., Hartzell, H. C. (2011) Physiological roles and diseases of Tmem16/anoctamin proteins: are they all chloride channels? Acta Pharmacol. Sin. 32, 685–692
162. Rock, J. R., Futtner, C. R., Harfe, B. D. (2008) The transmembrane protein TMEM16A is required for normal development of the murine trachea. Dev. Biol. 321, 141–149
163. Guilbault, C., Saeed, Z., Downey, G. P., Radzioch, D. (2007) Cystic fibrosis mouse models. Am. J. Respir. Cell Mol. Biol. 36, 1–7
164. Wong, X. M., Younger, S., Peters, C. J., Jan, Y. N., Jan, L. Y. (2013) Subdued, a TMEM16 family Ca²⁺-activated Cl⁻channel in Drosophila melanogaster with an unexpected role in host defense. eLife 2, e00862
165. Saitta, M., Cavalier, S., Garay, R., Cragoe, Jr., E., Hannaert, P. (1990) Evidence for a DIOA-sensitive [K+,Cl2-cotransport system in cultured vascular smooth muscle cells. Am. J. Hypertens. 3, 939–942
166. Lauf, P. K., Bauer, J., Adragna, N. C., Fujise, H., Zade-Oppen, A. M., Ryu, K. H., Delpire, E. (1992) Erythrocyte K-Cl cotransport: properties and regulation. Am. J. Physiol. 263, C917–C932
167. Lauf, P. K., Adragna, N. C. (2000) K-Cl cotransport: properties and molecular mechanism. Cell. Physiol. Biochem. 10, 341–354
168. Delpire, E., Mount, D. B. (2002) Human and murine phenotypes associated with defects in cation-chloride cotransport. Annu. Rev. Physiol. 64, 803–843.